<DOC>
	<DOCNO>NCT01729702</DOCNO>
	<brief_summary>The primary purpose study demonstrate change plasma level circulate neurohormone ( mainly BNP NT-proBNP ) , measure rest post-exercise correlate exercise functional limitation ( assessed exercise peak VO2 ) exercise ultrasonic parameter ( leave ventricular filling , obstruction , mitral regurgitation )</brief_summary>
	<brief_title>Neurohormonal Parameters Hypertrophic Cardiomyopathies</brief_title>
	<detailed_description>The secondary purpose study kinetics secretion natriuretic peptide , relationship extent MRI myocardial fibrosis degree exercise functional limitation .</detailed_description>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Cardiomyopathy , Hypertrophic</mesh_term>
	<criteria>Age 18 75 year Primary ( sarcomeric ) hypertrophic cardiomyopathy , obstructive non obstructive , study exercise peak oxygen consumption cardiac MRI gadolinium lateenhancement Informed consent Patient social insurance Patient rest Age 18 75 year Primary ( sarcomeric ) hypertrophic cardiomyopathy , obstructive non obstructive Informed consent Patient social insurance Insufficient echogenicity Permanent atrial fibrillation Complete BBB ECG LVEF &lt; 35 % Previous septal ablation ( surgical percutaneous ) Simultaneous participation another biomedical research If exercise need : contraindication exercise : hemodynamic instability , uncontrolled high blood pressure ( &gt; 220/120 mmHg ) , severe aortic stenosis Inability exercise ( muscular , pulmonary , elderly patient )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>1- Hypertrophic cardiomyopathy</keyword>
	<keyword>2- BNP</keyword>
	<keyword>3- NT-proBNP</keyword>
	<keyword>4- Neurohormons</keyword>
</DOC>